Target Hospitality (TH)
(Delayed Data from NSDQ)
$11.37 USD
+0.09 (0.80%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $11.39 +0.02 (0.18%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth B Momentum B VGM
Price, Consensus and EPS Surprise
TH 11.37 +0.09(0.80%)
Will TH be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for TH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TH
Royal Caribbean Cruises Ltd. (RCL) Hits Fresh High: Is There Still Room to Run?
Are Investors Undervaluing Target Hospitality (TH) Right Now?
TH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Royal Caribbean Cruises Ltd. (RCL) Hit a 52 Week High, Can the Run Continue?
Surging Earnings Estimates Signal Upside for Target Hospitality (TH) Stock
Target Hospitality (TH) Upgraded to Buy: Here's What You Should Know
Other News for TH
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
Theratechnologies (THTX) Gets a Buy from JonesTrading
What's Driving AZZ Inc's Surprising 11% Stock Rally?
Private Capital's Strategic Moves in Q1 2024: Spotlight on KKR & Co Inc
Theratechnologies Shareholders Elect Directors, Appoint Auditors